Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Oliveri, R. S."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chiu, C. W., Hiemstra, I. H., ten Hagen, W., Snijdewint‐Nkairi, R., de Jong, B., Garrido Castro, P., Kweekel, C., Oliveri, R. S., Elliot, B., Wielgos‐Bonvallet, M., Szafer‐Glusman, E., Schuurhuis, D., Blaedel, J., Ahmadi, T., Breij, E., Sasser, A.K., Jure‐Kunkel, M.
Publikováno v:
Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-2, 2p
Autor:
Uccelli, Antonio, Laroni, Alice, Brundin, Lou, Clanet, Michel, Fernandez, Oscar, Nabavi, Seyed Massood, Muraro, Paolo A., Oliveri, Roberto S., Radue, Ernst W., Sellner, Johann, Soelberg Sorensen, Per, Sormani, Maria Pia, Wuerfel, Jens Thomas, Battaglia, Mario A., Freedman, Mark S., Bonetti, Bruno, Rush, Carolina, Herrera, Concepción, Ramo Tello, Cristina, Miller, David, Szwajcer, David, Strunk, Dirk, Wall, Donna, Aguera-Morales, Eduardo, Rohde, Eva, Dazzi, Francesco, Comi, Giancarlo, Martino, Gianvito, Izquierdo Ayuso, Guillermo, Rabinovitch, H., MacLean, Heather, Marriott, James, Racosta, Juan, Arab, Leila, Gimona, Mario, Introna, Martino, Blinkenberg, Morten, Aghdami, Naser, Ali, Rehiana, Vosoughi, Reza, Nicholas, Richard, Marrie, Ruth Ann, Karimi, Shahedeh
Publikováno v:
Trials
Trials, Vol 20, Iss 1, Pp 1-13 (2019)
Uccelli, A, Laroni, A, Brundin, L, Clanet, M, Fernandez, O, Nabavi, S M, Muraro, P A, Oliveri, R S, Radue, E W, Sellner, J, Soelberg Sorensen, P, Sormani, M P, Wuerfel, J T, Battaglia, M A, Freedman, M S, Bonetti, B, Rush, C, Herrera, C, Ramo Tello, C, Miller, D, Szwajcer, D, Strunk, D, Wall, D, Aguera-Morales, E, Rohde, E, Dazzi, F, Comi, G, Martino, G, Izquierdo Ayuso, G, Rabinovitch, H, MacLean, H, Marriott, J, Racosta, J, Arab, L, Gimona, M, Introna, M, Blinkenberg, M, Aghdami, N, Ali, R, Vosoughi, R, Nicholas, R, Marrie, R A & Karimi, S 2019, ' MEsenchymal StEm cells for Multiple Sclerosis (MESEMS) : a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis ', Trials, vol. 20, 263 . https://doi.org/10.1186/s13063-019-3346-z
Trials, Vol 20, Iss 1, Pp 1-13 (2019)
Uccelli, A, Laroni, A, Brundin, L, Clanet, M, Fernandez, O, Nabavi, S M, Muraro, P A, Oliveri, R S, Radue, E W, Sellner, J, Soelberg Sorensen, P, Sormani, M P, Wuerfel, J T, Battaglia, M A, Freedman, M S, Bonetti, B, Rush, C, Herrera, C, Ramo Tello, C, Miller, D, Szwajcer, D, Strunk, D, Wall, D, Aguera-Morales, E, Rohde, E, Dazzi, F, Comi, G, Martino, G, Izquierdo Ayuso, G, Rabinovitch, H, MacLean, H, Marriott, J, Racosta, J, Arab, L, Gimona, M, Introna, M, Blinkenberg, M, Aghdami, N, Ali, R, Vosoughi, R, Nicholas, R, Marrie, R A & Karimi, S 2019, ' MEsenchymal StEm cells for Multiple Sclerosis (MESEMS) : a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis ', Trials, vol. 20, 263 . https://doi.org/10.1186/s13063-019-3346-z
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system with a degenerative component, leading to irreversible disability. Mesenchymal stem cells (MSC) have been shown to prevent inflammation and neurodegeneration in animal m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff5a51efd293cc2af33f29087e4b0499
https://doi.org/10.1186/s13063-019-3346-z
https://doi.org/10.1186/s13063-019-3346-z
Autor:
Sehested M; Department of Pathology, Rigshospitalet, Copenhagen, Denmark. maxwell@rh.dk, Wessel I, Jensen LH, Holm B, Oliveri RS, Kenwrick S, Creighton AM, Nitiss JL, Jensen PB
Publikováno v:
Cancer research [Cancer Res] 1998 Apr 01; Vol. 58 (7), pp. 1460-8.